|
ASTRAZENECA PLC A, (AZN) Stock Research Free Stock Rating
|
|
| |
| Company Profile |
| |
|
AstraZeneca PLC, a pharmaceutical company, engages in the research, development, manufacture, and marketing of prescription pharmaceuticals, as well as the supply of healthcare services worldwide. It provides medicines designed to fight disease in areas of medical need, such as cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory. The companys product portfolio includes Casodex, Arimidex, and Faslodex for treating cancer; disease Nexium for gastrointestinal problems; Symbicort for asthma; Atacand for treating hypertension; Crestor for treating high cholesterol; Zomig for treating migraine; and Seroquel for treating schizophrenia. AstraZeneca has strategic alliance with Cambridge Antibody Technology (CAT) for discovering and developing human antibody therapeutics in inflammatory disorders. In addition, it also engages in research and development, manufacture, and marketing of medical devices and implants for use in healthcare. The company was incorporated in 1992 and was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in 1999. AstraZeneca PLC is headquartered in London.
|
ASTRAZENECA PLC A Related |
|
AstraZeneca International biosciences company engaged in the research, development, manufacture, and marketing of ethical pharmaceuticals, agricultural and specialty chemicals products, and the supply of healthcare services.
|
|
AstraZeneca United States Learn about AstraZeneca, one of the world's leading pharmaceutical companies, and get information on our medicines, research, careers, and more.
|
|
AstraZeneca - Wikipedia, the free encyclopedia www.astrazeneca.com. AstraZeneca PLC[2] (LSE: AZN, OMX: AZN, NYSE: AZN), is a large Anglo-Swedish ... AstraZeneca - History, merger of Astra AB and Zeneca ...
|
|
